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Background Patients with renal insufficiency experience worse prognosis
after STEMI. 
Aim of the study to compare primary PCI (PPCI) and thrombolysis results
as well as in-hospital mortality after successful reperfusion between patients
with or without renal dysfunction (RD).
Methods From January 1995 to October 2014, 1588 patients admitted for
STEMI were enrolled in our registry. Two reperfusion groups were identified:
PPCI (315 patients) and thrombolysis (379 patients). We compared the group
of RD patients (RD+) and normal renal function patients (RD). Our main end-
points were: (1) The success of reperfusion and (2) the in-hospital mortality.
Results Ninety patients (13%) had RD, 50% of which underwent PPCI,
and 50% received thrombolytics. In the PPCI group, although TIMI flow was
similar before angioplasty (p=0.82), TIMI III flow restoration was signifi-
cantly lower in the RD+ group (78.6% vs 91.8%, p=0.013). 
Suboptimal result was also higher in the RD+ group (13.6% vs 2.7%,
p<0.001), but ST regression after TIMI III achievement was similar in the
2 groups (p=0.43) reflecting probably no microvascular damage. 
In the thrombolysis group, successful reperfusion was also significantly lower
when RD exists (58% vs 74%, p=0.03), but RD was not an independent predictor
of thrombolysis failure. RD was an independent mortality predictor either after
PPCI or thrombolysis (respectively p=0.014, OR=4.39 and p=0.006, OR=4.93).
After successful reperfusion, in-hospital mortality was higher among RD+
patients in the PPCI group (33.3% vs 4.3%, p<0.001), whereas it was similar
after successful thrombolysis (p=0.42).
In-hospital mortality was higher in RD+ patients when mechanically reper-
fused (40% vs 18.2%, p=0.024), whereas no significant difference was found
among RD- patients (p=0.75). 
Conclusion RD reduces PPCI success. 
Although RD was an independent mortality predictor regardless of the reper-
fusion strategy, prognosis was worse in RD group only after successful PPCI.
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Introduction and objectives In moderate or high risk non-ST segment ele-
vation acute coronary syndrome, clinical practice guidelines recommend a
coronary angiography with intent to revascularize. However, evidence to sup-
port this recommendation in very elderly patients is poor.
Methods All patients over 85 years old (military hospitals of Algeria)
admitted between 2006 and 2014 with a diagnosis of non-ST segment eleva-
tion acute coronary syndrome were retrospectively included. Using a propen-
sity score, patients undergoing the interventional approach and those
undergoing conservative management were matched and compared for sur-
vival and survival without ischemic events.
Results We included 167 consecutive patients with a mean age of 88 years
(range: 85 to 101). Those in the interventional approach group (n=67) were
younger, with a higher proportion of males and less comorbidity, less cogni-
tive impairment and lower troponin I levels compared with patients in the con-
servative management group (n=100). 
We matched 60patients from the interventional approach group and 60
from the conservative management group using propensity score. In the
matched patients, the interventional approach group exhibited better survival
(log rank 4.24; P=0.039) and better survival free of ischemic events (log rank
8.63; P=0.003) at the 3-year follow-up. In the whole population, adjusted for
propensity score quintiles, the interventional approach group had lower mor-
tality (hazard ratio 0.52; 95% confidence interval: 0.32-0.85) and a better sur-
vival free of ischemic events (hazard ratio 0.48; 95% confidence interval:
0.32-0.74).
Conclusions Nearly all the very elderly patients admitted with non-ST seg-
ment elevation acute coronary syndrome were of moderate or high risk. In
these patients, the interventional approach was associated with overall better
survival and better survival free of ischemic events.
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Aims Fractional flow reserve (FFR) invasively assesses the ischemic poten-
tial of coronary stenosis.FFR value of 0.75 has been referred to the ischemic
FFR threshold validated against non-invasive functional testing; while an FFR
value of 0.80 has guided clinical decision making in multicenter clinical trials.
Revascularization in case of FFR values in the gray zone between 0.75-0.80
is still debatable. We investigated the clinical outcome of patients with an iso-
lated stenosis and FFR value in the gray zone. 
Methods From 1997 to 2013, we retrospectively included all patients with
single segment disease at coronary angiography and FFR between 0.70-0.85.
We defined the following FFR groups: a) 0.70-0.75; b) 0.76-0.80 (gray zone);
Abstratct 0456 – Table: Reperfusion rates, types, timing and adjunctive medications among the age groups
Age groups 
<65 years
n=3476
65-74 years
n=1238
75-84 years
n=1147
85 years
n=308 P-value
No reperfusion, n (%) 3.8 5.6 8.0 13.6 <0.001
Fibrinolysis, n (%) 1853 (53.3) 593 (47.9) 449 (39.2) 87 (28.3) <0.001
Primary PCI, n (%) 1492 (42.9) 576 (46.5) 606 (52.8) 179 (58.1) <0.001
Delay (first medical contact to PPCI), median (IQR), min 80 (58-123) 85 (60-125) 85 (64-130) 84 (60-124) 0.1
Bivalirudin*, n/N (%) 81/1197 (6.8) 30/429 (7.0) 48/373 (12.9) 28/121(23.1) <0.001
GPI*, n/N (%) 1375/2695 (51.0) 493/963 (51.2) 435/879 (49.5) 85/222 (38.3) 0.003
* Calculated among patients undergoing a coronarography. Bivalirudin has been used since 2008.
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c) 0.81-0.85. Study endpoints was death, myocardial infarction and revascu-
larization up to 5 years follow up. 
Results Out of 17380 patients undergoing FFR measurement: 2781 (16%)
patients presented lesions with FFR in the gray zone; 1459 were included: 449
treated with percutaneous revascularization (PCI) and 1010 with medical
therapy (MT). Clinical characteristics were similar among patients treated
with PCI or MT, with exception of more frequent male gender in PCI group
[p=0.002]. Diameter stenosis and FFR value were lower in PCI group
(p<0.0001). At 5-years, compared to PCI group, MACE was more frequent in
MT group with FFR 0.70-0.75 (11 [21%] vs. 53 [12%], p=0.026), while no
difference was observed in MT groups with FFR 0.75-0.80 and 0.81-0.85.
Within the MT group, a progressive increase in MACE was observed in 3 FFR
strata (FFR, 0.81-0.85: 58 [8%] vs. FFR, 0.76-0.80: 35 [13%] vs. FFR, 0.70-
0.75: n=11 [21%], p<0.0001).
Conclusions Patients with stenosis located in proximal-mid coronary seg-
ments and FFR in the gray zone of 0.75-0.80 demonstrate a MACE rate that
is still higher than than observed in patients above the 0.80 clinical threshold.
These data suggest that FFR £0.80 is valid to guide clinical decision making.
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Rationale and aim Introduced in early 2000, Fractional Flow Reserve
(FFR) was initially validated for deferring percutaneous coronary intervention
(PCI) when >0.80. After September 2012, FAME2 suggested performing PCI
when FFR <0.80. The impact of the two indications on routine practice is
poorly documented.
Methods Rate and indications of FFR use and decision for PCI was
assessed monthly between April 1999 and Sept 2014 in a single center. 
We calculated monthly the rates of FFR, coronary angiography (CA) and
PCI. 
Cumulative curves for CA, PCI and FFR we determined the according to
time elapsed since 1999.
Results In a single center, 26629 CA, 12270 PCI and 2454 FFR were per-
formed between 1999 and 2014. Monthly rates were 182 CA, 77 PCI and
14 FFR. The cumulative curves showed that the rates of CA and PCI were
stable, with a near-perfect linear correlation for each time interval. Con-
versely, there was a change in the rate of FFR, the best spline point for the
FFR use was found in September 2012. From 1999 to Sept 2012, the rate of
FFR was 14/month and increased to 21/month after Sept 2012. There was no
significant difference in the patient characteristics, indications for CA or
center team or equipment between the 2 periods, but the rate of FFR/CA
increased from 7.3 to 12%.
Conclusion Physicians performed more FFR after Sept 2012. This increase
in routine use of FFR was only explained by the additional indication for FFR
resulting from the publication of the FAME2 study.
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Introduction To evaluate feasibility, image quality and radiation dose of
CCTA in patients with atrial fibrillation (AF) using a new generation 256-
MDCT.
Methods and materials Thirty consecutive patients (mean HR
103.8±52.2 bpm) with AF underwent CCTA on a 256-MDCT (Revolution
CT, General Electric). Prevalence and impact on diagnosis of motion and
step artifacts were independently evaluated by two experienced readers
using a 3-point scale (0: no artifact; 1: artifacts without interference on
diagnosis; 2: artifacts interfere with diagnosis) and percentage of assess-
able coronary segments was calculated. Contrast-to-noise ratio (CNR) and
signal-to-noise ratio (SNR) were measured for quantitative assessment.
Radiation dose was evaluated by calculating the mean effective dose (ED).
Results On a per-patient analysis, all the coronary segments were assessable
in 28 (93%) patients. Only 3 coronary segments were not assessable in 2 patients
due to motion artefacts resulted in a coronary segments assessability of 99.3%
(453/456 segments) in the overall population. No step artifact was observed
whereas motion artefacts (3-point scale score of 0.53±0.6) were infrequent and
do not interfere with diagnosis. The mean CNR and mean SNR were respectively
13.3±4.6 and 13.0±3.3. ED remains low with an average of 3.3±2.5 mSv. 
Conclusion CCTA is feasible in AF patients using a new generation 256-
MDCT providing good image quality and low radiation dose in this chal-
lenging population.
The author hereby declares no conflict of interest
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